| PERIOD ENDING | 31-Mar-04 | | Total Revenue | 12,310 | | Cost of Revenue | 1,620 | | | Gross Profit | 10,690 | | | Operating Expenses | | Research Development | 647 | | Selling General and Administrative | 4,698 | | Non Recurring |
-
| | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 5,345 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 163 | | Earnings Before Interest And Taxes | 5,508 | | Interest Expense |
-
| | Income Before Tax | 5,508 | | Income Tax Expense | 45 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 5,463 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 5,463 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $5,463 |
|
1.52% Nasdaq 0.00%
Income Statement
